Search
for
Sort by
Research 571–600 of 1000+
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness
- Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- Getting to the root of hair loss in alopecia
- Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases
- A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Dose-dependent valproate-induced alopecia in patients with mental disorders
- Arctiin blocks hydrogen peroxide-induced senescence and cell death though microRNA expression changes in human dermal papilla cells
- Tetrahydroxystilbene Glucoside Effectively Prevents Apoptosis Induced Hair Loss
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Evaluation of film-forming sprays with Origanum marjoram extracts for treating Alopecia areata induced by cyclophosphamide in a rabbit model
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Chemotherapy and Cutaneous Drug Reactions
- Tri-Culture Fermentation of Neem (Azadirachta indica) Leaves Induces Phytochemical Remodeling and Enhances Multi-Target Bioactivities Relevant to Androgenetic Alopecia
- Mixed-Culture Fermentation of Coffee Pulp Induces Metabolomic Changes and Enhances Multi-Target Bioactivity Relevant to Androgenetic Alopecia
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Physical methods for topical skin drug delivery: concepts and applications
- Isotretinoin for the treatment of facial lichen planopilaris: A new indication for an old drug, a case series study
- Anti-Alopecia Activity of Alkaloids Group from Noni Fruit against Dihydrotestosterone-Induced Male Rabbits and Its Molecular Mechanism: In Vivo and In Silico Studies
- Novel drugs of United States Food and Drug Administration approved in 2024
- Efficacy of Percutaneous Superficial Temporal Arterial Hyaluronidase Injection for Hyaluronic Acid Filler–Induced Necrosis of Frontotemporal Skin and/or the Ipsilateral Scalp With Subsequent Alopecia
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata